From: Variation in serum urate levels in the absence of gout and urate lowering therapy
Characteristic | Study population (n = 85) | Normouricemic at Screening (n = 72) | Hyperuricemic at Screening (n = 13) |
---|---|---|---|
Age at Enrollment (mean ± SD) | 27.8 ± 7.0 | 27.9 ± 7.1 | 27.4 ± 7.3 |
Sex | |||
Male | 52 (61%) | 39 (54%) | 13 (100%) |
Female | 33 (39%) | 33 (45%) | 0 (0%) |
Race/Ethnicity | |||
White | 45 (53%) | 37 (51%) | 8 (62%) |
African-American | 35 (41%) | 32 (45%) | 3 (23%) |
Other | 5 (6%) | 3 (4%) | 2 (15%) |
BMI (mean ± SD) | 31.1 ± 7.9 | 30.8 ± 8.1 | 32.4 ± 6.6 |
Screening Serum urate (mean ± SD, mg/dL) | 5.8 ± 1.2 | ||
Men | 6.4 ± 1.0 | ||
Women | 4.9 ± 0.7 |